Strategic Wealth Partners, Ltd. Edwards Lifesciences Corp Transaction History

Strategic Wealth Partners, Ltd.

$947 Million
Q3 2024

A detailed history of Strategic Wealth Partners, Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 5,251 shares of EW stock, worth $351,869. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,251

Previous 20,397 74.26%

Holding current value

$351,869

Previous $1.88 Million 81.63%

% of portfolio

0.04%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$59.7 - $93.78 $904,216 - $1.42 Million	-15,146 Reduced 74.26%	5,251 $346,000
Q2 2024 Oct 08, 2024	BUY	$84.3 - $94.31 $135,723 - $151,839	1,610 Added 8.57%	20,397 $1.88 Million
Q1 2024 May 20, 2024	BUY	$72.54 - $95.56 $309,310 - $407,467	4,264 Added 29.36%	18,787 $1.8 Million
Q4 2023 May 20, 2024	BUY	$61.71 - $77.76 $219,996 - $277,214	3,565 Added 32.53%	14,523 $1.11 Million
Q3 2023 May 20, 2024	BUY	$69.28 - $93.38 $500,548 - $674,670	7,225 Added 193.54%	10,958 $759,000
Q2 2023 May 20, 2024	SELL	$81.41 - $94.33 $3,256 - $3,773	-40 Reduced 1.06%	3,733 $352,000
Q1 2023 Apr 24, 2023	SELL	$74.26 - $84.51 $275,727 - $313,785	-3,713 Reduced 49.6%	3,773 $312,000
Q4 2022 Apr 24, 2023	SELL	$68.3 - $87.44 $532,808 - $682,119	-7,801 Reduced 51.03%	7,486 $558,000
Q3 2022 Apr 24, 2023	BUY	$82.37 - $107.29 $17,050 - $22,209	207 Added 1.37%	15,287 $1.26 Million
Q2 2022 Aug 22, 2022	SELL	$86.5 - $128.27 $396,256 - $587,604	-4,581 Reduced 23.3%	15,080 $1.43 Million
Q1 2022 May 19, 2022	BUY	$101.96 - $128.34 $41,395 - $52,106	406 Added 2.11%	19,661 $2.31 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $205,719 - $252,735	1,934 Added 11.17%	19,255 $2.49 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $195,529 - $233,225	1,900 Added 12.32%	17,321 $1.96 Million
Q2 2021 Aug 25, 2021	BUY	$83.84 - $104.76 $522,071 - $652,340	6,227 Added 67.73%	15,421 $1.6 Million
Q1 2021 May 24, 2021	BUY	$78.68 - $90.67 $126,753 - $146,069	1,611 Added 21.24%	9,194 $769,000
Q4 2020 Feb 18, 2021	BUY	$71.69 - $91.23 $154,061 - $196,053	2,149 Added 39.55%	7,583 $692,000
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $365,110 - $475,148	5,434 New	5,434 $434,000
Q2 2019 Aug 06, 2019	SELL	$55.74 - $64.41 $1,560 - $1,803	-28 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$46.41 - $56.94 $1,299 - $1,594	28 New	28 $1,000
Q3 2018 Dec 06, 2018	SELL	$45.7 - $58.03 $914 - $1,160	-20 Closed	0 $0
Q2 2018 Sep 04, 2018	SELL	$42.45 - $51.3 $2,419 - $2,924	-57 Reduced 74.03%	20 $3,000
Q1 2018 Jul 13, 2018	BUY	$37.19 - $47.45 $2,863 - $3,653	77 New	77 $11,000

Others Institutions Holding EW

# of Institutions

1,356

Shares Held

468M

Call Options Held

2.45M

Put Options Held

2.56M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.

Account

Strategic Wealth Partners, Ltd. Edwards Lifesciences Corp Transaction History